Key result
Adding a single troponin below the limit of detection to a low-risk HEART score achieved 100% sensitivity for acute myocardial infarction.
Why the study?
Does combining a low-risk HEART score or ACS Pretest Probability Assessment with a single troponin below the LOD improve the sensitivity to rule out AMI and 30-day MACE in ED patients?
Cohort (n=888)
No
Does combining a low-risk HEART score or ACS Pretest Probability Assessment with a single troponin below the LOD improve the sensitivity to rule out AMI and 30-day MACE in ED patients?
Adding a single troponin below the limit of detection to clinical risk scores improves sensitivity to 100% for ruling out 30-day MACE in emergency department patients.
Answers are grounded in this paper and cite their sources.
May support 30-day MACE rule-out in ED with low-risk scores plus troponin below LOD; hypothesis-generating and requires prospective validation.
When screening for acute myocardial infarction (AMI), troponin levels below the 99th percentile, including those below the limit of detection (LOD), are considered normal. We hypothesized that a low-risk HEART score (0-3) or ACS Pretest Probability Assessment <2% plus a single troponin below the LOD would rule out both AMI and 30-day major adverse cardiac events (MACE). We studied all patients who presented to a single academic emergency department and received a troponin I (Siemens Ultra Troponin I) from September 1, 2013, to November 13, 2013 (n=888). Demographic and clinical data were abstracted from the electronic medical record. Primary outcome was a final encounter diagnosis of myocardial infarction. Secondary outcome was 30-day MACE, defined as composite of myocardial infarction, revascularization, or death from a cardiac or uncertain etiology. Sensitivities of low-risk HEART score and ACS Pretest Probability <2% alone were 98% (95% confidence interval [CI], 89%-100%) and 96% (95% CI, 86%-100%) for AMI and 94% (95% CI, 86%-98%) and 95% (95% CI, 88%-99%), respectively, for 30-day MACE. When combined with troponin below the LOD, sensitivity for AMI was 100% (95% CI, 93%-100%; difference 2%; 95% CI, -2% to 6%) for low-risk HEART Score and 100% (95% CI, 93%-100%; difference 4%; 95% CI, -1.5% to 10%) for ACS Pretest Probability <2%. When combined with troponin below the LOD, sensitivity for 30-day MACE was 100% (95% CI, 95%-100%; difference 6%; 95% CI, 1%-12%) for low-risk HEART Score and 100% (95% CI, 95%-100%; difference 5%; 95% CI, 0.2%-10%) for ACS Pretest Probability <2%. Addition of a single troponin below the LOD to these scores improves sensitivity for 30-day MACE.
No takes yet. Share an insight, caveat, or question.
Datlow et al. (2017) conducted a cohort in Acute myocardial infarction (n=888). Low-risk HEART score or ACS Pretest Probability <2% plus troponin below limit of detection vs. Clinical scores alone was evaluated on Final encounter diagnosis of myocardial infarction (difference 2%, 95% CI -2% to 6%). Adding a single troponin below the limit of detection to a low-risk HEART score achieved 100% sensitivity for acute myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: